Indole and benzimidazole derivatives

US8008335B2 · kind B2 · utility

Assignee

• Novartis Vaccines and Diagnostics, Inc. · US

Inventors

• Rustum Boyce · San Francisco, US
• Yi Xia · South San Francisco, US
• Hongyan Guo · San Mateo, US
• Kris Mendenhall · Concord, US
• Annette Walter · Mill Valley, US
• Weibo Wang · Moraga, US

Key dates

• Filing date: Oct 14, 2005
• Grant date: Aug 30, 2011
• Expiry date: Jul 16, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula (I).